Ishii, Koji

Publishing since 1965 (Dinosaur)

Has published 676 publications in 46 years

Number of publications published per year by Ishii, Koji. (Source : PubMed)

Distribution of publications types for Ishii, Koji. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Zhang YY, Zhang BH, Ishii K, Liang TJ. Novel function of CD81 in controlling hepatitis C virus replication.  J. Virol.  2010;84;7  
•  Itoi T, Sofuni A, Itokawa F, Kurihara T, Tsuchiya T, Ishii K, Tsuji S, Ikeuchi N, Moriyasu F. Transpapillary incision of refractory circumscript pancreatic duct stricture using wire-guided snare forceps.  World J. Gastroenterol.  2010;16;12  
•  Guo YM, Ishii K, Hirokawa M, Tagawa H, Ohyagi H, Michishita Y, Ubukawa K, Yamashita J, Ohteki T, Onai N, Kawakami K, Xiao W, Sawada K. CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells.  Blood  2010  
•  Masaki T, Suzuki R, Saeed M, Mori KI, Matsuda M, Aizaki H, Ishii K, Maki N, Miyamura T, Matsuura Y, Wakita T, Suzuki T. Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.  J. Virol.  2010  
•  Ogasawara Y, Ishii K. Exposure to chrysotile asbestos causes carbonylation of glucose 6-phosphate dehydrogenase through a reaction with lipid peroxidation products in human lung epithelial cells.  Toxicol. Lett.  2010  
•  Kono H, Fujii H, Ishii K, Hosomura N, Ogiku M. Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats.  Transl Res  2010;155;3  
•  Hmwe SS, Aizaki H, Date T, Murakami K, Ishii K, Miyamura T, Koike K, Wakita T, Suzuki T. Identification of hepatitis C virus genotype 2a replicon variants with reduced susceptibility to ribavirin.  Antiviral Res.  2010;85;3  
•  Ishii K, Tanaka S, Kagami K, Henmi K, Toyoda H, Kaise T, Hirano T. Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells.  Cancer Invest.  2010;28;3  
•  Uesawa Y, Motege E, Dai Y, Ishii K, Mohri K. Prediction models for feverishness developed during interferon therapy of chronic hepatitis C patients.  Pharmazie  2010;65;2  
•  Ishii K, Matsumoto M, Takahashi Y, Okada E, Watanabe K, Tsuji T, Takaishi H, Nakamura M, Toyama Y, Chiba K. Risk Factors for Development of Subaxial Subluxations Following Atlantoaxial Arthrodesis for Atlantoaxial Subluxations in Rheumatoid Arthritis.  Spine  2010  

[ See timeline ] [ See all publications ]